AstraZeneca selects Dendrite to provide technology platform to U.K. sales group



Under the terms if the contract, Dendrite will provide full-scale implementation, training and on-going support of it's WebForce product suite, linking over 900 representatives into a common sales force effectiveness (SFE) system.

After conducting a thorough review of the SFE products and services currently available, AstraZeneca UK ultimately chose Dendrite because of the Company's unique attributes which include a singular focus and understanding of the sales processes within the healthcare market combined with a proven delivery ability, said Angela Rees, Head of Business Information AstraZeneca UK. Additionally, by utilizing Dendrite's WebForce solution, AstraZeneca UK gets the benefit of having one partner for software, implementation and support, as well as the comfort of knowing that the initial platform established is flexible for developing future customer information based requirements.